antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting blockbuster sales for rival Beyfortus. In the study, clesrovimab (MK-1654) significantly ...

If approved by the 10th June action date, clesrovimab could start competing with Sanofi and AstraZeneca's fast-growing Beyfortus (nirsevimab) – which got the go-ahead from the US regulator in ...

Investors with a lot of money to spend have taken a bullish stance on AstraZeneca AZN. And retail traders should know. We noticed this today when the positions showed up on publicly available ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 18,745.88 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

After hours: 7:46:25 pm GMT-5 ...

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is ...